About ArsenalBio
ArsenalBio is a privately held, programmable cell therapy company focused on the realization of solid tumor cell therapy to defeat cancer. Our discovery engine comprises precise CRISPR-enabled genome editing, integrated circuits incorporating logic gates for improved tumor targeting, and therapeutic enhancements enabling multiple pharmaceutical functions. With our programmable and computationally driven approach, we aim for enhanced and broader efficacy, increased patient safety, reduced provider costs and expanded market access. Our team is engineering living medicines to attack cancer’s inherent multi-faceted nature and bring dramatic improvements to the lives of patients.
|
|
|
51-200 employees
View all ArsenalBio employees
|
|
Biotechnology Research
|
|
South San Francisco , CA 94080, US
|
|
2019
|
|
Biotechnology, Technology, Artificial Intelligence, Machine Learning, Cancer, Cell Therapy, Immunology
|
ArsenalBio Alternatives
Frequently Asked Questions about ArsenalBio
Ken Drazan is the CEO of ArsenalBio. To contact Ken Drazan email at [email protected] or [email protected].
ArsenalBio Staff Directory
Search ArsenalBio Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
